NO920678L - Terapeutiske peptider - Google Patents

Terapeutiske peptider

Info

Publication number
NO920678L
NO920678L NO92920678A NO920678A NO920678L NO 920678 L NO920678 L NO 920678L NO 92920678 A NO92920678 A NO 92920678A NO 920678 A NO920678 A NO 920678A NO 920678 L NO920678 L NO 920678L
Authority
NO
Norway
Prior art keywords
amino acid
active site
acid residue
peptide
peptide bond
Prior art date
Application number
NO92920678A
Other languages
English (en)
Other versions
NO302619B1 (no
NO920678D0 (no
Inventor
David H Coy
Jacques-Pierre Moreau
Sun Hyuk Kim
Original Assignee
Biomeasure Inc
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc, Univ Tulane filed Critical Biomeasure Inc
Publication of NO920678D0 publication Critical patent/NO920678D0/no
Publication of NO920678L publication Critical patent/NO920678L/no
Publication of NO302619B1 publication Critical patent/NO302619B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO920678A 1989-08-21 1992-02-20 Analogifremgangsmåte for fremstilling av et terapeutisk peptid NO302619B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39716989A 1989-08-21 1989-08-21
US07/502,438 US5084555A (en) 1989-08-21 1990-03-30 An octapeptide bombesin analog
PCT/US1990/004646 WO1991002746A1 (en) 1989-08-21 1990-08-17 Therapeutic peptides

Publications (3)

Publication Number Publication Date
NO920678D0 NO920678D0 (no) 1992-02-20
NO920678L true NO920678L (no) 1992-04-06
NO302619B1 NO302619B1 (no) 1998-03-30

Family

ID=27015776

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920678A NO302619B1 (no) 1989-08-21 1992-02-20 Analogifremgangsmåte for fremstilling av et terapeutisk peptid

Country Status (12)

Country Link
US (1) US5084555A (no)
EP (1) EP0489089B1 (no)
JP (1) JPH04506664A (no)
AT (1) ATE139540T1 (no)
AU (1) AU648037B2 (no)
CA (1) CA2064896A1 (no)
DE (1) DE69027533T2 (no)
DK (1) DK0489089T3 (no)
ES (1) ES2090140T3 (no)
FI (1) FI920737A0 (no)
NO (1) NO302619B1 (no)
WO (1) WO1991002746A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US5767236A (en) * 1990-05-09 1998-06-16 Biomeasure, Inc. Linear therapeutic peptides
US5620959A (en) * 1990-07-31 1997-04-15 Glaxo Wellcome Inc. Bombesin antagonists
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
AU4238493A (en) * 1992-05-08 1993-12-13 Thomas Jefferson University IGF-1 analogs
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
GB0009918D0 (en) * 2000-04-20 2000-06-07 Rose Keith Covalent capture facilitating purification of polypeptides
EP1260229A3 (en) * 2001-05-18 2002-12-11 Sumitomo Pharmaceuticals Company, Limited Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity
US7858737B2 (en) * 2002-08-26 2010-12-28 Wisconsin Alumni Research Foundation Heterogeneous foldamers containing α, β, and/or γ-amino acids
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
NZ564694A (en) 2003-04-22 2009-11-27 Sod Conseils Rech Applic Peptide vectors
US8101580B2 (en) 2005-04-21 2012-01-24 Astellas Pharma Inc. Therapeutic agent for irritable bowel syndrome
CA2858907A1 (en) * 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
KR20090085599A (ko) * 2006-10-02 2009-08-07 바이엘 쉐링 파마 악티엔게젤샤프트 Ｐｅｔ 영상화용 규소 유도체
JP2010520229A (ja) * 2007-03-01 2010-06-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 放射性弗素化方法
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
CN104328100B (zh) 2008-06-12 2019-08-23 益普生生物创新有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (en) 2008-12-18 2010-06-23 University Of Miami Polypeptide bombesin antagonists
EP3920961A4 (en) 2019-02-08 2022-12-14 United States Government as represented by the Department of Veterans Affairs GROWTH HORMONE RELEASING HORMONE ANTAGONISTS AND THEIR USES
SG11202112276RA (en) * 2019-05-21 2021-12-30 Eyebio Korea Novel peptide compound or pharmaceutically acceptable salt thereof
CN116333041A (zh) * 2023-04-10 2023-06-27 湖南中晟全肽生化有限公司 一种激活grp受体的多肽化合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) * 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4650661A (en) * 1982-09-15 1987-03-17 Aktiebolaget Hassle Enzyme inhibitors
ATE37552T1 (de) * 1982-10-18 1988-10-15 Ici Plc Peptid- und pseudopeptid-derivate.
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
WO1989002897A1 (en) * 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds

Also Published As

Publication number Publication date
US5084555A (en) 1992-01-28
NO302619B1 (no) 1998-03-30
AU6294090A (en) 1991-04-03
ATE139540T1 (de) 1996-07-15
EP0489089B1 (en) 1996-06-19
EP0489089A1 (en) 1992-06-10
DE69027533T2 (de) 1996-12-19
WO1991002746A1 (en) 1991-03-07
DE69027533D1 (de) 1996-07-25
NO920678D0 (no) 1992-02-20
FI920737A0 (fi) 1992-02-20
JPH04506664A (ja) 1992-11-19
AU648037B2 (en) 1994-04-14
CA2064896A1 (en) 1991-02-22
EP0489089A4 (en) 1992-06-24
ES2090140T3 (es) 1996-10-16
DK0489089T3 (da) 1996-07-29

Similar Documents

Publication Publication Date Title
DK0489089T3 (da) Terapeutiske peptider
HK1010785A1 (en) Therapeutic peptides
ES2065336T3 (es) Peptidos terapeuticos.
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
AU5258898A (en) Mutant forms of fas ligand and uses thereof
ES2062514T5 (es) Sistema de procesamiento de levadura que comprende un aminoacido cargado negativamente adyacente al sitio de procesamiento.
ES526201A0 (es) Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria
EP0557418A4 (en) A -g(b)-type transforming growth factor
HU906872D0 (en) Therapeutic peptides
DE69528531D1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
Kiso et al. Neo‐kyotorphin (Thr—Ser—Lys—Tyr—Arg), a new analgesic peptide
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
PT95057A (pt) Processo para a preparacao de peptidos terapeuticos
ES2078964T3 (es) Enzima recombinante alfa-amidante del extremo c-terminal de origen del tiroides humano.